Lorazepam Tablet
Product Images NDC 71610-768

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Lorazepam (NDC 71610-768). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aphena Pharma Solutions - Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Bottle Label 2 mg (71610 0768 53)

Lorazepam USP 2 mg oral tablets, packaged with 60 tablets per container. The label includes storage instructions, warnings to keep out of reach of children, and notes the medication is a C-IV controlled substance. Manufactured by Aphena Pharma Solutions - Tennessee, LLC, with the product NDC 71610-0768-53 and batch information visible.*

FDA Label Image

Aphena Pharma Solutions (TN)

FDA Label Image

1 (Spl Lorazepam Tablet Structure)

Chemical structure diagram of lorazepam showing its molecular composition with chlorine-substituted benzene rings, a lactam ring, and various functional groups including hydroxyl and amide.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.